Patent expiry and biosimilars: difference between revisions
Diff·revision 2 → 3·14:17, 25 Dec 2024
Difference between revision 2 and revision 3 of Patent expiry and biosimilars. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 2 — 01:58, 17 Dec 2024 CoI_Corin (talk) add category for drug regulation 1,842 bytes +515 | Revision 3 — 14:17, 25 Dec 2024 MoveRequestMio (talk) correct the description of the shortage-list mechanism 1,842 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |